Adalimumab for Crohnʼs disease in clinical practice at Mayo clinic: The first 118 patients-Reference-Cited by-同舟云学术

Adalimumab for Crohnʼs disease in clinical practice at Mayo clinic: The first 118 patients

Published:2010-11 Issue:11 Volume:16 Page:1912-1921
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Swoger Jason M.,Loftus Edward V.,Tremaine William J.,Faubion William A.,Pardi Darrell S.,Kane Sunanda V.,Hanson Karen A.,Harmsen Scott W.,Zinsmeister Alan R.,Sandborn William J.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference19 articles.

1. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort

2. Long-Term Evolution of Disease Behavior of Crohn's Disease

3. American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease

4. Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

5. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?;Journal of Clinical Medicine;2021-11-15

2. Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis;Journal of Clinical Medicine;2021-05-14

3. Review article: investigation and management of internal fistulae in Crohn’s disease;Alimentary Pharmacology & Therapeutics;2021-03-15

4. Fistulizing Crohn's disease;Current Problems in Surgery;2020-11

5. Dose Augmentation of Tumor Necrosis Factor Inhibitors is Frequently Performed in Persons With Inflammatory Bowel Disease in the Absence of Objective Evidence of Active Inflammation;Journal of Clinical Gastroenterology;2020-07-17